472 related articles for article (PubMed ID: 22306179)
1. Notch signaling in human development and disease.
Penton AL; Leonard LD; Spinner NB
Semin Cell Dev Biol; 2012 Jun; 23(4):450-7. PubMed ID: 22306179
[TBL] [Abstract][Full Text] [Related]
2. Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.
Hofmann JJ; Briot A; Enciso J; Zovein AC; Ren S; Zhang ZW; Radtke F; Simons M; Wang Y; Iruela-Arispe ML
Development; 2012 Dec; 139(23):4449-60. PubMed ID: 23095891
[TBL] [Abstract][Full Text] [Related]
3. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
McCright B; Lozier J; Gridley T
Development; 2002 Feb; 129(4):1075-82. PubMed ID: 11861489
[TBL] [Abstract][Full Text] [Related]
4. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.
Andersson ER; Chivukula IV; Hankeova S; Sjöqvist M; Tsoi YL; Ramsköld D; Masek J; Elmansuri A; Hoogendoorn A; Vazquez E; Storvall H; Netušilová J; Huch M; Fischler B; Ellis E; Contreras A; Nemeth A; Chien KC; Clevers H; Sandberg R; Bryja V; Lendahl U
Gastroenterology; 2018 Mar; 154(4):1080-1095. PubMed ID: 29162437
[TBL] [Abstract][Full Text] [Related]
5. Renal involvement and the role of Notch signalling in Alagille syndrome.
Kamath BM; Spinner NB; Rosenblum ND
Nat Rev Nephrol; 2013 Jul; 9(7):409-18. PubMed ID: 23752887
[TBL] [Abstract][Full Text] [Related]
6. Human Jagged 1 mutants cause liver defect in Alagille syndrome by overexpression of hepatocyte growth factor.
Yuan ZR; Kobayashi N; Kohsaka T
J Mol Biol; 2006 Feb; 356(3):559-68. PubMed ID: 16403414
[TBL] [Abstract][Full Text] [Related]
7. The developmental biology of genetic Notch disorders.
Mašek J; Andersson ER
Development; 2017 May; 144(10):1743-1763. PubMed ID: 28512196
[TBL] [Abstract][Full Text] [Related]
8. Jagged1 (JAG1): Structure, expression, and disease associations.
Grochowski CM; Loomes KM; Spinner NB
Gene; 2016 Jan; 576(1 Pt 3):381-4. PubMed ID: 26548814
[TBL] [Abstract][Full Text] [Related]
9. Biological function of mutant forms of JAGGED1 proteins in Alagille syndrome: inhibitory effect on Notch signaling.
Boyer-Di Ponio J; Wright-Crosnier C; Groyer-Picard MT; Driancourt C; Beau I; Hadchouel M; Meunier-Rotival M
Hum Mol Genet; 2007 Nov; 16(22):2683-92. PubMed ID: 17720887
[TBL] [Abstract][Full Text] [Related]
10. Functional role of Notch signaling in the developing and postnatal heart.
Nemir M; Pedrazzini T
J Mol Cell Cardiol; 2008 Oct; 45(4):495-504. PubMed ID: 18410944
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling in normal and disease States: possible therapies related to glycosylation.
Rampal R; Luther KB; Haltiwanger RS
Curr Mol Med; 2007 Jun; 7(4):427-45. PubMed ID: 17584081
[TBL] [Abstract][Full Text] [Related]
12. Notch signalling pathway and human diseases.
Joutel A; Tournier-Lasserve E
Semin Cell Dev Biol; 1998 Dec; 9(6):619-25. PubMed ID: 10075489
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling Pathway.
Joutel A; Monet M; Domenga V; Riant F; Tournier-Lasserve E
Am J Hum Genet; 2004 Feb; 74(2):338-47. PubMed ID: 14714274
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the Notch ligand Jagged1 missense mutant proteins underlying Alagille syndrome.
Tada M; Itoh S; Ishii-Watabe A; Suzuki T; Kawasaki N
FEBS J; 2012 Jun; 279(12):2096-107. PubMed ID: 22487239
[TBL] [Abstract][Full Text] [Related]
15. The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome.
Loomes KM; Underkoffler LA; Morabito J; Gottlieb S; Piccoli DA; Spinner NB; Baldwin HS; Oakey RJ
Hum Mol Genet; 1999 Dec; 8(13):2443-9. PubMed ID: 10556292
[TBL] [Abstract][Full Text] [Related]
16. The genetics and ocular findings of Alagille syndrome.
Kim BJ; Fulton AB
Semin Ophthalmol; 2007; 22(4):205-10. PubMed ID: 18097983
[TBL] [Abstract][Full Text] [Related]
17. JAG1 Mutation Spectrum and Origin in Chinese Children with Clinical Features of Alagille Syndrome.
Li L; Dong J; Wang X; Guo H; Wang H; Zhao J; Qiu Y; Abuduxikuer K; Wang J
PLoS One; 2015; 10(6):e0130355. PubMed ID: 26076142
[TBL] [Abstract][Full Text] [Related]
18. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1.
Li L; Krantz ID; Deng Y; Genin A; Banta AB; Collins CC; Qi M; Trask BJ; Kuo WL; Cochran J; Costa T; Pierpont ME; Rand EB; Piccoli DA; Hood L; Spinner NB
Nat Genet; 1997 Jul; 16(3):243-51. PubMed ID: 9207788
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of JAG1 gene mutations in Polish patients with Alagille syndrome.
Jurkiewicz D; Gliwicz D; Ciara E; Gerfen J; Pelc M; Piekutowska-Abramczuk D; Kugaudo M; Chrzanowska K; Spinner NB; Krajewska-Walasek M
J Appl Genet; 2014 Aug; 55(3):329-36. PubMed ID: 24748328
[TBL] [Abstract][Full Text] [Related]
20. CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk.
Peters N; Opherk C; Zacherle S; Capell A; Gempel P; Dichgans M
Exp Cell Res; 2004 Oct; 299(2):454-64. PubMed ID: 15350543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
